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ABSTRACT: Following a 6-h inhalation exposure to
aerosolized 20 and 110 nm diameter silver nanoparticles,
lung tissues from rats were investigated with X-ray absorption
spectroscopy, which can identify the chemical state of silver
species. Lung tissues were processed immediately after sacrifice
of the animals at 0, 1, 3, and 7 days post exposure and the
samples were stored in an inert and low-temperature
environment until measured. We found that it is critical to
follow a proper processing, storage and measurement protocol;
otherwise only silver oxides are detected after inhalation even
for the larger nanoparticles. The results of X-ray absorption
spectroscopy measurements taken in air at 85 K suggest that the dominating silver species in all the postexposure lung tissues
were metallic silver, not silver oxide, or solvated silver cations. The results further indicate that the silver nanoparticles in the
tissues were transformed from the original nanoparticles to other forms of metallic silver nanomaterials and the rate of this
transformation depended on the size of the original nanoparticles. We found that 20 nm diameter silver nanoparticles were
significantly modified after aerosolization and 6-h inhalation/deposition, whereas larger, 110 nm diameter nanoparticles were
largely unchanged. Over the seven-day postexposure period the smaller 20 nm silver nanoparticles underwent less change in the
lung tissue than the larger 110 nm silver nanoparticles. In contrast, silica-coated gold nanoparticles did not undergo any
modification processes and remained as the initial nanoparticles throughout the 7-day study period.
■ INTRODUCTION
Engineered nanomaterials (ENMs), such as silver nanoparticles
(AgNPs), have been used in many existing technologies and
may impact many future applications.1 For example, AgNPs are
being explored in inhalation therapy for respiratory infections
and allergic airway inflammation because of their potent
antimicrobial properties.2−5 These ENMs will eventually end
up in the environment, and human exposure by multiple routes,
including inhalation, is likely.6 For example, pulmonary
exposure to AgNPs can occur during manufacturing. Another
possible exposure is to aerosol sprays or via inhalation of water
droplets containing AgNPs.7 The toxicity of AgNPs that is
responsible for their medicinal use has been investigated,8−21
which is attributed to the toxicity of Ag+ ions in aqueous
solution, a species that possess antimicrobial properties and is
found to react with various biomolecules.22−29 Given that
AgNPs can enter the lungs through inhalation and AgNPs may
be potentially toxic, it is important to know the impact of
ENMs such as AgNPs on the human body but especially the
lung, where they will likely deposit when inhaled.
The determination of the actual Ag species in the lungs at
different stages following deposition is important for under-
standing the origin of toxicity for AgNPs. Unlike other more
stable nanomaterials such as gold nanoparticles, AgNPs may be
significantly modified in the body and especially in the lungs,
which are both an oxidizing and reducing environment.30−33
Lability of AgNPs has been extensively demonstrated. For
example, AgNPs dissolve in water at different pH and in the
cellular and biological environment to form Ag ions.21,34−36
These ions may undergo various transformations in different
chemical environments. For instance, Ag+ ions can be reduced
to form small nanoparticles in pants or other environments.37,38
It is also known that Ag in Au/Ag core−shell nanostructures
(∼80 nm in diameter) dissolve in water under X-ray irradiation
and much smaller (<5 nm) AgNPs are formed. The dissolved
Ag ions are chemically reduced by species available in solution,
such as solvated electrons generated in water under X-ray
irradiation. This again suggests that large AgNPs can dissolve
and reform into smaller AgNPs in a redox environment.39 On
the basis of these findings, it is entirely possible that AgNPs
may be partially or completely modified and continue to change
in the lungs, and it is critical to identify and track transient Ag
species in the lungs as a means to determine their eventual fate
and understand those factors that may contribute to toxic
effects.
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Several analytical methods can characterize the physicochem-
ical properties of nanomaterials in the lungs, although each has
its own shortcomings. Inductively coupled plasma−mass
spectrometry (ICP-MS) and recent work using autometallog-
raphy can help locate small amounts of Ag in the lungs.21,40
However, critical chemical information such as oxidation state
and whether the original AgNPs stay intact or are dissolved and
reduced to form smaller AgNPs cannot be revealed using these
methods. Traditional centrifuge separation in combination with
atomic absorption spectroscopy cannot conclusively assign the
chemical state of Ag species because small (∼1 nm diameter)
Ag neutral nanoparticles may stay in the supernatant after
centrifugation, even at 13 000 rpm or filtered with mem-
branes.41,42 X-ray photoelectron spectroscopy (XPS) may be
used to identify the chemical state of the nanomaterials and
their derivatives.43 However, sample preparation is difficult and
strict measurement conditions are required. In addition, the
sample size is extremely small because XPS is a surface probe
approach, so only a small portion of the sample is probed.
Electron microscopy, such as transmission electron microscopy
(TEM), may be difficult to employ to study the chemical state
of ENMs in the environment and body because of the
limitation of being able to only perform basic elemental
analysis.44 As a result, none of the reported methods can detect
the needed physicochemical properties of Ag species in the
lungs, information that is key to understanding the observed
biological responses to AgNPs.
X-ray absorption spectroscopy (XAS) is a powerful method
to study the properties of ENMs in biological systems including
the lungs.45 XAS is equivalent to a local electron diffraction
method that can probe the chemical environment or local,
short-range order around a specific X-ray absorbing element,
which can be Ag if AgNPs are under investigation. XAS can
determine at least two critical chemical parameters: chemical
shift and local bonding environment. These parameters can
help reveal the dominant transient Ag species. The first
parameter can be used to determine the oxidation state of the
element under investigation. The second can be used to infer
the size or surface area of nanoparticles and whether Ag species
are in metallic nanoparticles, oxide nanoparticles or dissolved in
water. The sensitivity of XAS is high, down to micrograms of
Ag in grams of tissues, suitable for detecting AgNPs in lung
tissues under inhalation conditions. In addition, X-rays are
highly penetrating, capable of studying most elements including
Ag and Au in mm thick samples. To date, XAS has been used to
study silver nanomaterials (AgNMs) in several different
background materials,46−50 predominantly at room temperature
and seldom at low temperatures.49,51 Hence XAS is a promising
method to determine chemical information on the Ag species in
the lungs.
One challenge for performing XAS measurements is that
those experiments are generally conducted at national facilities
and it is critical to minimize changes occurring to ENMs in lung
tissues retrieved after an in vivo, preferably inhalation, exposure.
These exposures are often conducted at specialized facilities far
from the site of eventual analysis. Because lung tissues are full
of oxidative and reducing agents, even after the animals are
sacrificed, Ag species may continuously change chemically until
XAS measurements are conducted. As a result, the samples and
experimental protocols have to be designed to eliminate further
evolution of the transient Ag species.
Here we present the outcome of the first attempt to use XAS
to characterize Ag species in rat lungs after inhalation exposure
of aerosolized AgNPs. In the following, the methods and results
are presented, followed by discussion of the results. We have
found that XAS can, in principle, be used to retrieve important
chemical information on the Ag species in the lungs from
animals that have undergone practical exposure scenarios, such
as inhalation of aerosolized ENMs. Through this study, we have
established proper protocols to employ XAS to study ENMs in
rat lungs after inhalation and have obtained results that may
help shed light on the mechanisms of transport and fate of
AgNPs in the lungs. The current work focuses on the study of
evolution of AgNPs in the lungs after deposition.
■ MATERIALS AND METHODS
Materials. AgNPs were manufactured by nanoComposix,
Inc. (San Diego, CA), and were supplied by the National
Institute of Environmental Health Sciences Centers for
Nanotechnology Health Implications Research (NCNHIR)
consortium. AgNPs were 20 and 110 nm in diameter and
stabilized with a citrate coating. AgNPs were at a concentration
of 1 mg/mL in 2 mM citrate aqueous solution and were stored
in the dark at 4 °C.
AuNPs@SiO2 Synthesis. 88 nm diameter gold nano-
particles (AuNP) cores were synthesized in a seed growth
method modified from an established protocol.52 First, a gold
seed solution was made by citrate reduction.53 Then 50 μL of
HAuCl4 was added to 150 mL of MilliQ (MQ) water. Once at
reflux and with vigorous stirring, 6 mL of 1 wt % sodium citrate
was injected rapidly. The solution was refluxed for 15 min and
then allowed to cool to room temperature. Seed growth was
performed in three sequential growth steps. 0.3 g of
poly(vinylpyrrolidone) (PVP) in 10 mL of MQ water was
added to the final solution. The PVP coating proceeded
overnight. Excess PVP was removed by centrifuging at 5.5k rpm
for 15 min. Centrifugation and washing was performed twice
and the AuNPs resuspended into 5 mL of MQ water. The 5 mL
of AuNPs was added to 37.5 mL of ethanol and 0.5 mL of 28
wt % NH3OH. With stirring, we added 0.5 mL of tetraethyl
orthosilicate (TEOS), and the reaction proceeded overnight.
The solution was purified by centrifuging and washing with 40
mL of MQ water five times. AuNPs@SiO2 samples were
collected.
Aerosolization of AgNPs and Inhalation. AgNPs were
aerosolized using a BGI 6-jet Collison nebulizer to produce
liquid aerosol droplets. The droplets were dehydrated using
two TSI diffusion dryers (3062, TSI) and charge was
neutralized using a Krypton-85 β-particle source prior to
delivery to the nose-only exposure unit.54,55 Excess particles
were scavenged from the exposure unit into a filter using a
vacuum pump. Particle mass concentration was determined
using gravimetric analysis of filters and particle number
concentration using a scanning mobility particle scanner
(SMPS, 3071/3010, TSI), which was also used to measure
the aerosol size.
Lung Sample Preparation. Twelve week old male
Sprague−Dawley rats were obtained from Harlan Laboratories
and acclimated 1 week prior to exposure. Rats were housed in
two per cage and provided Laboratory Rodent Diet (Purina
Mills, St Louis, MO) and water ad libitum. All animal
experiments were performed under protocols approved by
the University of California Davis IACUC in accordance with
National Institutes of Health guidelines. Rats were conditioned
to the exposure tubes in the week prior to exposure by being
housed in tubes for progressively longer periods of time. Rats
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were exposed once to an aerosol of 20 or 110 nm AgNPs for 6
h. Animals were euthanized at the end of exposure (T0), or at 1
(T1), 3 (for 20 nm AuNPs only, T3), and 7 days (T7) post
exposure using Beuthanasia-D at 7.5 mL/kg and exsanquina-
tion. The abdominal and thoracic cavities were opened, the
trachea cannulated and the lung was removed en block. The
lung was immediately filled with helium at 30 cm water
pressure and frozen in 2-methylbutane over liquid nitrogen. A
1.0−1.5 mm section was cut from of the center of the left lobe,
secured between two layers of clear adhesive tape and stored at
−80 °C in an argon purged storage box.
XAS Data Collection and Processing. XAS, which
includes both extended X-ray absorption fine structure
(EXAFS) and X-ray absorption near edge spectroscopy
(XANES), was employed to determine the oxidation state
and local chemical structure of the Ag species in the lung. Both
methods are useful in revealing the chemical state of the
element of interest.56,57 The patterns of XANES of the samples
and different standards are often adequate to directly reveal the
chemical state of the element of interest. EXAFS requires
simulation but often providing more detailed structural
information on the elements of interest.
The XAS experiments were conducted at beamline 7−3 at
the Stanford Synchrotron Radiation Lightsource (SSRL). The
beamline (Si (220) monochromator) was optimized to detect
X-ray fluorescence of Ag or Au in the samples, while reducing
the scattering from the soft tissues and ice in the background.
Data collection was performed either at room temperature or at
85 K. For measurements performed at 85 K, the immediately
frozen and inertly stored lung samples were cooled to 85 K
using a liquid helium thermal station. EXAFS data (K edge of
Ag and L edge of Au) were measured using a multiple element
Ge detector, and each sample took more than 6 h to measure.
The signals from all the detector elements were summed to
obtain the EXAFS raw data. The background in the raw data
was removed and the EXAFS oscillation was obtained. EXAFS
data was processed using SIXPack.58 The k range data was
selected, deglitched, and then Fourier transformed (FT) to the
real space. Interatomic distances (R), coordination numbers
(N), and disorders (Debye−Waller factor or σ) were then
optimized to fit the EXAFS data in the k space. Standard
deviation of the fitting parameter is estimated by changing the
parameter to double the fitting error. XANES spectra were
processed similarly, although no FT was used and no fitting was
performed. As a control, lung samples were also prepared and
stored at room temperature without the inert environment and
measured at room temperature as well. The XAS data was
processed similarly as described above.
In analyzing EXAFS data, we selected EXAFS in the energy
space from 25565 to 26050 eV for Ag measurements,
corresponding to k reciprocal space of 2−14 Å−1, which is
broader than commonly used in the literature to retrieve AgNP
structural information in environmental samples.46,51 Generally
speaking, the broader the k data range, the higher quality of
EXAFS data. The broader range used here is enabled by low
temperature (85 K) measurements and hence provides more
accurate EXAFS data and higher quality fittings.
Oxidation state (os) information was retrieved by examining
the chemical shift obtained from XANES data. Second
derivative was taken against each XANES trace, and chemical
shift (CS) of the samples was calibrated against the same
internal reference of a thin silver foil at room temperature for
each measured sample. For data with large noise at the
inflection point, analytical formulas were created to fit the first
derivative near the inflection point and then the shifts of the
XANES patterns were determined. Oxidation state can be
calculated by comparing the chemical shift of the samples to
Figure 1. EXAFS results in reciprocal (A−C) and real (D−F) space. The samples include 110 nm (A/D) and 20 nm (B/E) AgNPs and several
reference samples (C/F). Figure D and F are the FT counterparts of the plots shown in panels A and C, respectively. The EXAFS data are displaced
vertically for visual clarity.
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that of Ag foil (os = 0.0) and AgNO3 (os = +1.0). No error was
assigned to the CS or os.
■ RESULTS
EXAFS data can directly reveal the nature of chemical bonding
environment through the examination of the position and the
amplitude of the peaks in EXAFS data for the dominating Ag
species in the lungs. Figure 1A and B show the EXAFS data in
the reciprocal space obtained at 85 K of the frozen and properly
stored lungs tissues exposed to 20 and 110 nm AgNPs at 0, 1, 3
(only for 20 nm), and 7 days. Figure 1D and E show the same
EXAFS results after FT into the real space. In the results shown
here (Figure 1D and E) there is only one dominant peak
between 1 and 3 Å in the real space for all seven samples (T0,
T1, T3, and T7). This peak corresponds to first Ag−Ag
coordination shell around the X-ray absorbing Ag or direct Ag−
Ag bonds in these samples. Other peaks at greater distances
represent higher-order coordination shells around the absorb-
ing Ag. There is little or no Ag−O peak. On the basis of this
information, we conclude that Ag species in all seven samples
are dominated by pristine metallic Ag. This is the first direct
evidence that Ag species carried into the lungs are metallic, not
oxides or sulfides, over an extensive period of time.
The amplitude of the peaks in the EXAFS data reveals how
the coordination number changes over time. Results shown in
Figure 1 display that the differences between EXAFS data for
20 and 110 nm AgNPs. For 110 nm AgNPs in the lungs as
shown in Figure 1D, Ag in T1 samples has a slightly lower
amplitude than that of Ag species in T0 samples. In contrast,
amplitude for T7 is less than half of that for T0 and T1 samples.
The decrease in the modulation amplitude for T7 sample is also
obvious in the energy space, as shown in Figure 1A. For
samples obtained with 20 nm AgNPs starting material (Figure
1E), on the other hand, the trend is similar but with two major
differences. The similarity is that there is little Ag−O/N/Cl/S
scattering and the main peak corresponds to Ag−Ag scattering.
The differences are (1) the amplitude of the EXAFS peak of T0
for 20 nm AgNPs is significantly lower than those of 110 nm
AgNPs at similar time points and (2) the change from day 0 to
day 7 is less significant for Ag obtained with 20 nm AgNPs than
110 nm AgNPs. These observations seem to agree with the
recently obtained inhalation toxicity data.40 From these data, it
is evident that 20 nm AgNPs were modified more significantly
at the onset of deposition, but followed by smaller changes over
the 7-day period than 110 nm AgNPs.
Several silver references or standards, including a metallic Ag
foil, 20 and 110 nm AgNPs and frozen Ag nitrate aqueous
solution were measured, and their results are shown in Figure
1C and F. Ag foil was the only sample that was measured at
room temperature while the rest were all measured at 85 K.
EXAFS results for T0 of 110 nm shown in Figure 1A and D are
similar to the pristine 110 nm AgNPs, but T0 data for 20 nm is
quite different from that of 20 nm pristine AgNPs: The 20 nm
T0 sample has a much lower EXAFS peak corresponding to
Ag−Ag scattering. Both 20 and 110 nm pristine AgNPs in
water are barely oxidized, as shown in Figure 1C and F, and
they are close to the pristine AgNPs. In contrast, there is no
Ag−Ag peak in Ag nitrate; only Ag−O or Ag−N bond appears
in frozen AgNO3 aqueous solution. The AgNO3 data in the R
space is obtained from the k space EXAFS data with slightly a
smaller range of k space data of 2−9 Å−1 because of the lack of
oscillation beyond this range, especially in the high k region. A
single peak corresponding to Ag−O is found from our
measurements. This peak is more difficult to observe if the
sample is measured at room temperature because of greater
disorder. The measured results of these references suggest that
the inhaled 20 and 110 nm AgNPs and their derivatives remain
metallic in rat lungs after 7 days, albeit the nanoparticles of two
sizes behaved differently.
We also measured AgNO3 and 110 nm AgNPs incubated in
artificial lung fluids (ALF) as well as 20 and 110 nm AgNPs in
O2 bubbled water. The results are shown in Supporting
Information Figure SI-1. AgNPs in O2 bubbled water did not
change significantly compared with pristine AgNPs. For AgNO3
in ALF, there was clearly white precipitate and the EXAFS
results in the real space show only the Ag−Cl peak; neither
Ag−O nor Ag−Ag peak exists. The source of Cl is most likely
from high salt concentration in ALF. Only AgCl precipitates
formed because of presence of Cl ions in ALF. Amplitude of
the main EXAFS peak for Ag in 110 nm AgNPs in ALF sample
is slightly lower than pristine AgNPs, implying that ALF could
do the same to AgNPs as the lungs did to the AgNPs. It is
Table 1. Fitting Parameters of the Average Coordination Number (N), Interatomic Distance or Bond Length (R), and Debye−
Waller Factor (σ) for the Ag Species in the Lung Samples Whose Results Shown in Figure 1a
Ag−Ag (2.880 Å), Ag−O (2.200 Å) and Ag−Cl (2.700 Å) peak fittings (EXAFS)
N R (Å) σ (Å2) CS (eV) (XANES)
110 nm AgNP 9.19 ± 0.682 2.887 ± 0.003 0.00339 ± 0.0003 −0.4
lung T0 110 nm 10.11 ± 1.27 2.887 ± 0.005 0.00340 ± 0.0006 0.0
lung T1 110 nm 10.09 ± 1.16 2.886 ± 0.004 0.00364 ± 0.0005 +0.4
lung T7 110 nm 4.87 ± 0.691 2.888 ± 0.005 0.00367 ± 0.0006 +0.6
110 nm AgNP + O2 10.08 ± 0.968 2.886 ± 0.004 0.00381 ± 0.0004 0.0
110 nm AgNP in ALF 8.63 ± 0.696 2.884 ± 0.003 0.00371 ± 0.0004 0.0
20 nm AgNP 8.58 ± 0.444 2.863 ± 0.002 0.00367 ± 0.0002 −1.4
lung T0 20 nm 5.69 ± 0.283 2.877 ± 0.002 0.00381 ± 0.0002 −2.3
lung T1 20 nm 5.75 ± 0.182 2.876 ± 0.001 0.00366 ± 0.0001 −2.9
lung T3 20 nm 5.01 ± 0.305 2.876 ± 0.002 0.00375 ± 0.0003 −2.1
lung T7 20 nm 3.50 ± 0.244 2.879 ± 0.003 0.00390 ± 0.0003 −2.0
Ag foil 7.15 ± 0.281 2.863 ± 0.002 0.00902 ± 0.0002 0.0
20 nm AgNP + O2 8.37 ± 0.424 2.875 ± 0.002 0.00361 ± 0.0002 −1.5
AgNO3 (Ag−O) 3.63 ± 3.48 1.989 ± 0.111 0.0158 ± 0.020 +2.4
AgNO3 in ALF (Ag−Cl) 4.46 ± 0.371 2.634 ± 0.006 0.00755 ± 0.0009 −2.2
aChemical shift (CS) values are obtained from XANES measurements described.
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worth pointing out that AgNPs were only incubated in ALF for
a few hours, possibly explaining the relatively small decrease in
amplitude of EXAFS signal in the R space shown in Supporting
Information Figure SI-1C.
Table 1 lists the fitted parameters of R (distance between two
scatters), Debye−Waller factors (disorder or σ) and coordina-
tion numbers N of the lung samples studied here and shown in
Figure 1. In fitting, the most intense peak between 1.0 and 3.0
Å corresponding to either Ag−Ag or Ag−O was isolated and
selected and then fitted to the selected data in a chosen k range
in the reciprocal space. The fitting is straightforward because of
the dominant peak for most of the samples. An example of the
peak isolation and fitting is shown in Supporting Information
Figure SI-2. This peak from each sample is fit independently.
Fitting results for AgNO3 samples are also listed.
On the basis of Table 1, it is clear that the two types of
AgNPs continue to change in the lungs after inhalation/
deposition. For 110 nm, there is no initial drop from pristine to
day 0 followed by a significant drop of 52% from T0/T1 of 10.0
± 1.2 to day 7 of 4.87 ± 0.70. Pristine 110 nm AgNPs and T0
Ag species have similar disorders, and N for the pristine AgNPs
(9.2 ± 0.7) and T0/T1 are within statistical errors. In contrast,
20 nm AgNPs behaved differently from the 110 nm AgNPs.
The average N for 20 nm before inhalation is 8.6 ± 0.4, with a
similar disorder to T0 sample. Immediately after inhalation, the
N of Ag in the lungs at T1 drops to 5.8 ± 0.19, a 33% drop that
may be caused by either the inhalation process or how rat lungs
take up these smaller nanoparticles. The N then only decreases
further down to 3.50 ± 0.24, another 39% drop over the next 7
days. Supporting Information Figure SI-3 summarizes the
results.
The disorder varies only slightly among these Ag species
measured at 85 K. The disorder is slightly less for the pristine
110 nm AgNPs and Ag species in T0 sample. However, Ag
species in the lungs derived from 110 nm AgNPs in T7 sample
have a similar disorder even these Ag species have a much lower
average N than the pristine AgNPs. The disorders of other
AgNPs measured at 85 K are similar, staying within ±7% of the
average value of 0.00365 Å2. The disorder for Ag foil, the only
sample measured at room temperature, is almost three times
that of other samples measured at 85 K and is very close to the
previous reported values.59 Disorder for AgNO3 is much higher,
due to the randomness in distance between Ag cations and
nearby oxygen or nitrogen in solution.
In addition to EXAFS measurements, XANES can more
directly detect small changes to the oxidation state of the Ag
species in the samples through the measurement of chemical
shift. The XANES results of the samples studied above are
shown in Figure 2. On the basis of Figure 2A, it is evident that
day 7 sample of 110 nm AgNPs has a smaller modulation
amplitude than that of day 0 or 1 sample in the XANES region.
The raw data showed the modulation amplitude in T7 XANES
data was about 50% of that T0 and T1, agreeing with the
EXAFS data. On the other hand, the decrease from T0 to T7 is
less for 20 nm samples.
The chemical shifts, which are represented by the inflection
points or the shifts of the first derivative patterns of the XANES
data, are listed in Table 1. The two benchmark samples are bulk
Ag foil and AgNO3, and the chemical shifts for these two
samples are 0.0 and +2.4 eV. It is clear that nitrate has a much
greater chemical shift than Ag foil in which Ag species should
be neutral. Ag species in 110 nm T0 sample and two other 110
Figure 2. XANES results of the inhaled 110 and 20 nm AgNPs and references samples.
Figure 3. XANES (A) and EXAFS (B/C) data for the AuNPs@SiO2. There is only one EXAFS peak in the real space in the direct bonding region of
1−3 Å. The changes over 7 days among the samples studied were minimal.
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nm AgNP control samples that are exposed to O2 and ALF
have approximately no charge. There are small amounts of
positive charge on Ag in the 110 nm T1 and T7 samples,
agreeing with the EXAFS data showing no Ag−O peak. In
contrast, all of the 20 nm AgNP samples including the pristine
20 nm AgNPs seem to have negative charge on them, meaning
that the Ag species are chemically reduced instead of oxidized.
As a control, we also investigated silica-coated gold
nanoparticles (AuNPs@SiO2). Because of the protection layer
of 20-nm thick SiO2, we did not expect this nanomaterial be
modified in the lungs. The results of AuNPs@SiO2 at T0 and
T7 day are shown in Figure 3. The background scattering from
ice/tissue is stronger due to the lower energy of X-rays used to
study the L edge of Au at approximately 13 keV. XANES data
shown in Figure 3A reveals no oxidation. From the EXAFS
data, which is shown in Figure 3B/C, it is also clear that no
oxidation occurred. It is important to note that the EXAFS data
of AuNPs@SiO2 in T0 and T7 samples are almost identical,
without much change to N, which is in contrast to those of
AgNPs shown in Figure 1D/E. It indicates that AuNPs were
largely the same after spending 7 days in the lungs, while
AgNPs underwent measurable transformations.
The sample preparation and measurement protocols are
critical to the success of the measurements. If not immediately
frozen and stored in the inert environment and measured at
low temperatures, the XAS results are invalid. The data of these
samples taken at room temperature is shown in Supporting
Information Figure SI-4. In contrast to immediately freezing/
storage in the inert environment, AgNPs stored exposed to air
and measured at room temperature were completely oxidized
and possibly dissolved. Supporting Information Figure SI-4A
shows the XANES results of these samples without immediate
freezing and storage in inert environment. Ag species of even
110 nm AgNPs in the lungs are mostly oxidized, similar to that
in AgNO3 (aq). Supporting Information Figure SI-4B and C
show the EXAFS results in the k and R space of the lung
samples without immediate freezing and storage in the inert
environment. It is clear that the quality of the data is poor in
the high k region, because of the much larger Debye−Waller
factors or disorder of the species under investigation at room
temperature. For 110 nm AgNPs, the peaks at the left of the
main peak became more prominent and the peak intensities
increase further for O2 bubbled AgNPs. In contrast, for 110 nm
AgNPs in the lungs, whether it is after 1 or 7 days, the Ag−Ag
peak largely disappeared, similar to that in the standard AgNO3
(aq). These results suggest that if the samples were not
properly prepared and stored, 110 nm AgNPs were completely
oxidized or even dissolved in the lungs after just 1 day because
of the extensive time of several weeks between the sample
preparation and XAS measurements. On the other hand, Ag
species still possess Ag−Ag scattering after O2 bubbling
through the AgNPs solution (aq) for 24 h. The results
shown here demonstrate the importance of properly treating
and measuring the samples in order to preserve the chemical
state of Ag species in lung tissues obtained post exposure.
■ DISCUSSION
The absorption changes shown in XANES raw data (not
shown) can be used to infer the amount of Ag in the samples,
which shows approximately the same amounts of Ag in all the
lungs at T0. These results are corroborated by an ICP-MS
study of the total amounts of Ag in the lung, which were 321
and 357 ng at T0 for 20 and 110 nm AgNPs following
inhalation.55 This shows that even small amounts of Ag species
deposited in the lung can be studied with XAS measurements
to reveal their chemical structures.
We did not investigate the effect of aerosolization and
inhalation process on the modification of AgNPs, which may
cause temporary aggregation to some AgNPs. We do not
believe that the aerosolization process alters the chemical state
of the Ag species in AgNPs. For 110 nm AgNPs, there was little
or no aggregation−the SMPS measurements suggested the size
of 110 nm.55 For 20 nm AgNPs, the SMPS measurements
showed the size of 77 nm, which may be caused by aggregation,
as well as by sodium citrate salt in the solution. Because the
nebulizer produces droplets with a mass medium diameter of
1.9 μm, each liquid droplet may contain single (110 nm AgNP)
or multiple (20 nm AgNPs) AgNPs. Upon drying, the final
product may contain either single AgNPs or aggregates of
several AgNPs. In the presence of citrate, such aggregation
generates little chemical modification to the Ag species in the
nanoparticles and once these nanoparticles are deposited on the
surface in the lung, they should behave similarly as individual
citrate-covered AgNPs.
It is interesting to note that the values of the average
coordination number N are small (around 3.5 to 5.5) for the Ag
species detected at the end of 7-day postexposure. These values
correspond to the N values for 3 and 6 nm diameter AgNPs
reported in the literature.51 For perfect crystalline Ag bulk, the
value of N should be close to 12.51 The value of N decreases as
the particle size reduces or surface area increases because there
are more surface atoms. Surface atoms in a 111 facet of a face-
center-cube crystalline structure have fewer than 9 neighbors
whereas the bulk atoms have 12. The atoms at the edges have
even fewer neighbors. However, even for a 100-atom
nanoparticle corresponding to a roughly 1.0 nm diameter
nanoparticle, the average N of the first coordination shell is
approximated 8.0 if the cluster is perfectly crystalline or
cuboctahedral.60,61 The low N measured here, and those shown
in the literature for small AgNPs, seems to suggest that these
Ag species may be contained in either very small AgNPs, of the
order 1 nm in diameter, or in highly porous larger sized (3−6
nm or even larger) Ag nanomaterials, possibly resembling Ag-
doped zeolites.49 This means that the Ag species in T7 may
contain a large portion of such new metallic Ag species that are
derived from the original 20 or 110 nm AgNPs.
The dominant metallic Ag species detected in the lungs
suggests that if Ag+ ions are responsible for the observed
toxicity, then those ions must be short-lived and be readily
reduced to neutral atoms chemically, which may form small
AgNPs. The fact that Ag−Ag scattering accounts for the only
major peak in EXAFS suggests that majority of Ag species in
the lungs at any time are in the form of small metallic
nanoparticles or highly porous metallic nanomaterials such as
zeolites.
The results also show that Ag species in the lungs derived
from 110 nm AgNPs change more quickly than 20 nm AgNPs
and the inhalation process itself seems to be able to modify the
smaller 20 nm AgNPs at the onset of inhalation, which does not
happen for 110 nm AgNPs. This seems to be in agreement with
a recent inhalation toxicity study.40 For 20 nm AgNPs, there
was more significant modification to the nanoparticles from
aerosolization to inhalation/deposition. On the other hand, the
change occurring to the inhaled 20 nm AgNPs over the 7 day
period after deposition is less marked than in the larger 110 nm
AgNPs. These findings suggest that size does play a role in
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determining the chemical fate of these nanomaterials in
animals.
There are several possible explanations for the formation of
smaller AgNPs in the T7 sample. The most plausible
explanation is that the surface Ag atoms were oxidized and
dissolved from the inhaled AgNPs and these dissolved atoms,
or ions, then form smaller AgNPs. Because the average
coordination number is only around 4.0 and because XAS is
an ensemble measurement, the average surface area of Ag
species in the measured volume must be large. Since the
average Ag species are still metallic, it means that the AgNPs
need to be broken down but the new Ag species must stay
nonoxidized through chemical reduction, which is possible in
the lungs. This proposed oxidation, dissolution and reformation
process has been observed in the past in a redox environment.39
We speculate that there might be temporary high concen-
trations of Ag+ ions around the original AgNPs as the
nanoparticles dissolve into ions that are immediately reduced
to metallic Ag atoms and then reform into small AgNPs. This
process continues until the AgNPs are depleted or the
concentration of Ag ions/atoms becomes too low to form
small nanoparticles. This way AgNPs continuously evolve until
Ag species are cleared from the lungs. The second possibility is
that most original large AgNPs were dissolved away and cleared
from the lungs on day 7, leaving behind only the newly formed
smaller AgNPs. However, in order for this scenario to be true,
the signal strength of T7 sample has to be much weaker (orders
of magnitude), which is not the case. The third possible
scenario is that there is no dissolution of AgNPs but just that
the smaller AgNPs in the original AgNPs solution were the
ones that remained in the lungs after larger AgNPs were cleared
from the lungs. Because larger AgNPs carry much more Ag, this
scenario also requires that the absolute amount of Ag in the
lungs decreases significantly at T7, which was not observed.
ICP-MS measurements of the dose of AgNPs in the lungs
found similar amounts of Ag species in the lungs 7 days after
inhalation exposure to 20 and 110 nm AgNPs, proving that
significant amounts of Ag species remain in the lungs for a
prolonged period of time.55 The fourth pathway is that AgNPs
simply become more porous as they are transformed into
zeolite-like nanomaterials.
The negative chemical shifts for Ag species derived from 20
nm AgNPs are uncommon since more often Ag is oxidized and
possesses positive chemical shifts. However, Ag or Au
nanoparticles may possess negative charges on the surface.62
If the surface area is large to give rise to small N, it is possible
that these Ag species may be negatively charged because of
interaction with ligands. Because the Ag species in all samples
are metallic, the negative charge on Ag species derived from 20
nm AgNPs does not show in the EXAFS data. It is intriguing
that the 20 and 110 nm or derivatives in the lungs had different
chemical shifts, a result that requires further scrutiny in the
future.
Our results suggest that it is possible to use XAS to study
inhaled AgNPs and determine the chemical state of the Ag
species in the lungs after inhalation. Important steps must be
taken to obtain the desired data that can be used to help
elucidate the transport and fate of AgNPs in the lungs. One of
the most critical procedures is that lung samples need to be
immediately frozen and stored in an inert environment to
ensure stoppage of the oxidation process after lung samples are
taken. It is also important to take measurements at low
temperatures to reduce noise at high k values and maintain a
weakly oxidizing environment.
■ CONCLUSIONS
We used extended X-ray absorption fine structure (EXAFS)
and X-ray absorption near edge spectroscopy (XANES) to
study AgNPs in the lungs. The samples were prepared after
inhalation of aerosolized AgNPs aqueous solution by rats and
the prepared lung samples were frozen in inert environment
immediately after inhalation exposure experiment. The 20 and
110 nm AgNPs in lung tissues were then measured at 85 K at
SSRL. XANES data suggest that all the AgNPs in day 0, 1, 3,
and 7 are metallic and AgNPs in day 7 sample were different
from those at day 0 and 1. EXAFS data confirmed that the
dominant Ag species in the lungs remain metallic throughout
the seven-day period and the nanoparticles were possibly
dissolved and smaller AgNPs or zeolite AgNMs are formed in
the lungs over the seven-day period. Furthermore, the rate of
change of these nanoparticles is size dependent and larger 110
nm AgNPs experienced more dramatic change over 7 day
period than the smaller 20 nm particles. Because XAS is an
ensemble measurement, the results shown here do not exclude
the existence of small amounts of Ag atoms or ions.
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